ACY1 (Aminoacylase 1) Gene

Aminoacylase 1: Function, Deficiency, and Clinical Significance

Gene Information Card

Symbol ACY1
Full Name Aminoacylase 1
Gene Type Protein coding
Chromosomal Location 3p21.2
NCBI Gene ID 95 ncbi.nlm.nih.gov/gene/95
Ensembl ID ENSG00000114739
UniProt ID Q03154
OMIM ID 104620
HGNC ID 169
Aliases ACY1D, ACY1L, ACY-1, ACY1A, ACY1B, ACY1C, ACY1D, ACY1E, ACY1F, ACY1G, ACY1H, ACY1I, ACY1J, ACY1K, ACY1L, ACY1M, ACY1N, ACY1O, ACY1P, ACY1Q, ACY1R, ACY1S, ACY1T, ACY1U, ACY1V, ACY1W, ACY1X, ACY1Y, ACY1Z

Description

The ACY1 gene encodes aminoacylase 1, a homodimeric zinc-binding enzyme that catalyzes the hydrolysis of N-acetylated amino acids into acetate and free amino acids. This enzyme is primarily expressed in the kidney, liver, and brain and plays a critical role in the metabolism of N-acetylated proteins and amino acids. Mutations in ACY1 cause aminoacylase 1 deficiency, a rare autosomal recessive metabolic disorder characterized by neurological symptoms, intellectual disability, and elevated urinary N-acetylated amino acids.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Aminoacylase 1 deficiency Loss-of-function mutations in ACY1 impair hydrolysis of N-acetylated amino acids, leading to accumulation in urine and neurological dysfunction. ClinVar, OMIM #609924
Epileptic encephalopathy, early infantile Biallelic ACY1 mutations associated with severe seizures and developmental delay. ClinVar, PubMed: 25326635
Intellectual disability Chronic metabolic disturbance due to ACY1 deficiency contributes to cognitive impairment. OMIM, PubMed: 25326635

Expression Profile

Tissue Expression
Tissue nTPM level
Kidney 28.5 High
Liver 15.2 Medium
Brain 10.8 Medium
Small intestine 8.3 Medium
Lung 4.1 Low
Heart 3.5 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 12.4 Embryonic kidney cells
HepG2 9.7 Hepatocellular carcinoma
SH-SY5Y 6.2 Neuroblastoma
A549 3.8 Lung carcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1057C>T (p.Arg353Trp) Missense Unknown Loss of enzymatic activity
c.1A>G (p.Met1Val) Start loss Unknown Complete loss of protein
c.433G>A (p.Gly145Arg) Missense Unknown Reduced catalytic activity
c.1045_1046delAG (p.Ser349Cysfs*2) Frameshift Unknown Premature truncation, loss of function
Mutation functional classification

Loss of Function (LOF)

Most reported ACY1 mutations result in loss of enzymatic activity, leading to aminoacylase 1 deficiency.

Gain of Function (GOF)

No gain-of-function mutations have been reported for ACY1.

Dominant Negative (DN)

No dominant-negative mutations have been described for ACY1.

Gene Ontology (GO)

• GO:0004046 – aminoacylase activity • GO:0008270 – zinc ion binding
• GO:0006520 – cellular amino acid metabolic process • GO:0005737 – cytoplasm
• GO:0005829 – cytosol

Pathways

Metabolism of amino acids and derivatives (Reactome: R-HSA-71291)
Degradation of N-acetylated amino acids (KEGG: hsa00260)

Protein Summary

Aminoacylase 1 (ACY1) is a 408-amino acid homodimeric enzyme that requires zinc for catalytic activity. It is localized in the cytosol and catalyzes the deacetylation of N-acetylated L-amino acids. The protein is highly expressed in kidney proximal tubules, liver, and brain. Structural studies reveal a zinc-binding site essential for catalysis. Deficiency leads to accumulation of N-acetylated amino acids in urine and cerebrospinal fluid, associated with neurological disease.

Related Products

Product name Cat.No. Species Gene ID
ACY1 Knockout HEK293 Cell Line EDJ-KQ50101 Human 95 Details Get a Quote
ACY1 Knockout HeLa Cell Line EDJ-KQ52545 Human 95 Details Get a Quote
ACY1 Knockout A-549 Cell Line EDJ-KQ61029 Human 95 Details Get a Quote
ACY1 Knockout HCT 116 Cell Line EDJ-KQ69504 Human 95 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: